Skip to main content
. 2019 Jun 28;11(7):909. doi: 10.3390/cancers11070909

Figure 3.

Figure 3

Frontal planar scintigraphy images in patient No. 4, in whom the primary PCC had higher uptake on 123I-MIBG scintigraphy (A) than on somatostatin receptor scintigraphy (OctreoScan™) (B). After one cycle of 131I-MIBG (C) scintigraphy during therapy) an upregulation of somatostatin receptors was noted and further therapy was given with 177Lu-DOTA-octreotate (D) scintigraphy during therapy).